Susquehanna began coverage on shares of Cavium Inc. (NASDAQ:CAVM) in a report released on Tuesday. The brokerage set a “positive” rating on the semiconductor provider’s stock.

CAVM has been the topic of several other reports. TheStreet upgraded Cavium from a “sell” rating to a “hold” rating in a research note on Friday, September 2nd. Needham & Company LLC restated a “buy” rating and issued a $66.00 target price on shares of Cavium in a research note on Thursday, August 25th. JPMorgan Chase & Co. restated an “overweight” rating on shares of Cavium in a research note on Tuesday, September 13th. Pacific Crest restated a “hold” rating on shares of Cavium in a research note on Wednesday, July 27th. Finally, Canaccord Genuity restated a “buy” rating and issued a $61.00 target price (down from $67.00) on shares of Cavium in a research note on Tuesday, June 7th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $59.72.

Analyst Recommendations for Cavium (NASDAQ:CAVM)

Shares of Cavium (NASDAQ:CAVM) opened at 57.14 on Tuesday. The company’s 50 day moving average price is $52.84 and its 200 day moving average price is $50.77. Cavium has a 12 month low of $35.90 and a 12 month high of $73.95. The company’s market capitalization is $3.31 billion.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/cavium-inc-cavm-now-covered-by-susquehanna.html

Cavium (NASDAQ:CAVM) last issued its earnings results on Tuesday, July 26th. The semiconductor provider reported $0.29 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.29. The firm had revenue of $107.20 million for the quarter, compared to analyst estimates of $106.70 million. Cavium had a positive return on equity of 4.39% and a negative net margin of 1.94%. The business’s revenue was up 5.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.41 earnings per share. Analysts expect that Cavium will post $1.45 EPS for the current fiscal year.

In other Cavium news, VP Arthur D. Chadwick purchased 10,000 shares of the stock in a transaction on Tuesday, August 16th. The stock was acquired at an average price of $51.94 per share, with a total value of $519,400.00. Following the transaction, the vice president now directly owns 102,845 shares of the company’s stock, valued at approximately $5,341,769.30. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Arthur D. Chadwick purchased 20,000 shares of the stock in a transaction on Thursday, August 25th. The shares were acquired at an average cost of $55.33 per share, with a total value of $1,106,600.00. Following the transaction, the vice president now directly owns 122,845 shares in the company, valued at $6,797,013.85. The disclosure for this purchase can be found here. Company insiders own 4.63% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Nomura Holdings Inc. raised its position in Cavium by 395.8% in the second quarter. Nomura Holdings Inc. now owns 26,757 shares of the semiconductor provider’s stock worth $1,033,000 after buying an additional 21,360 shares during the last quarter. Royal Bank of Canada raised its position in shares of Cavium by 72.3% in the second quarter. Royal Bank of Canada now owns 1,151,942 shares of the semiconductor provider’s stock valued at $44,465,000 after buying an additional 483,391 shares in the last quarter. Public Employees Retirement System of Ohio raised its position in shares of Cavium by 20.3% in the second quarter. Public Employees Retirement System of Ohio now owns 71,060 shares of the semiconductor provider’s stock valued at $2,743,000 after buying an additional 11,983 shares in the last quarter. Amalgamated Bank raised its position in shares of Cavium by 2.1% in the second quarter. Amalgamated Bank now owns 5,945 shares of the semiconductor provider’s stock valued at $300,000 after buying an additional 120 shares in the last quarter. Finally, Metropolitan Life Insurance Co. NY raised its position in shares of Cavium by 5.5% in the second quarter. Metropolitan Life Insurance Co. NY now owns 40,492 shares of the semiconductor provider’s stock valued at $1,563,000 after buying an additional 2,098 shares in the last quarter. 93.97% of the stock is owned by institutional investors and hedge funds.

Cavium Company Profile

Cavium, Inc is a provider of semiconductor processors, which enables processing for wired and wireless networking, communications, storage, cloud, wireless, security, video and connected home and office applications. The Company’s products include OCTEON, OCTEON Fusion, OCTEON XL, LiquidIO, NITROX, NEURON Search, ThunderX, Xpliant and XPA.

5 Day Chart for NASDAQ:CAVM

Receive News & Ratings for Cavium Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavium Inc. and related companies with MarketBeat.com's FREE daily email newsletter.